129 related articles for article (PubMed ID: 32623397)
1. Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios.
Hayashi K; Gonzales TK; Kapoor A; Ziegler TE; Meethal SV; Atwood CS
J Alzheimers Dis; 2020; 76(3):1029-1046. PubMed ID: 32623397
[TBL] [Abstract][Full Text] [Related]
2. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
3. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
4. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia.
Tsolaki M; Grammaticos P; Karanasou C; Balaris V; Kapoukranidou D; Kalpidis I; Petsanis K; Dedousi E
Hell J Nucl Med; 2005; 8(1):39-42. PubMed ID: 15886752
[TBL] [Abstract][Full Text] [Related]
5. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
6. Age and cognitive status dependent differences in blood steroid and thyroid hormone concentrations in intact male rats.
Maliković J; Feyissa DD; Kalaba P; Marouf BS; Höger H; Hartmann MF; Wudy SA; Schuler G; Lubec G; Aradska J; Korz V
Behav Brain Funct; 2019 Jun; 15(1):10. PubMed ID: 31256760
[TBL] [Abstract][Full Text] [Related]
7. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.
Atwood CS; Bowen RL
Horm Behav; 2015 Nov; 76():63-80. PubMed ID: 26188949
[TBL] [Abstract][Full Text] [Related]
8. Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer's Disease.
O'Caoimh R; Gao Y; Svendrovski A; Illario M; Iaccarino G; Yavuz BB; Kehoe PG; Molloy DW
J Alzheimers Dis; 2019; 68(4):1499-1510. PubMed ID: 30909214
[TBL] [Abstract][Full Text] [Related]
9. Risk Assessment During Longitudinal Progression of Cognition in Older Adults: A Community-based Bayesian Networks Model.
Han H; Qin Y; Ge X; Cui J; Liu L; Luo Y; Yang B; Yu H
Curr Alzheimer Res; 2021; 18(3):232-242. PubMed ID: 34102974
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
11. Episodic-Memory Performance in Machine Learning Modeling for Predicting Cognitive Health Status Classification.
Bergeron MF; Landset S; Tarpin-Bernard F; Ashford CB; Khoshgoftaar TM; Ashford JW
J Alzheimers Dis; 2019; 70(1):277-286. PubMed ID: 31177223
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
[TBL] [Abstract][Full Text] [Related]
13. Correlations between sex-related hormones, alcohol dependence and alcohol craving.
Ho AM; Geske JR; Bakalkin G; Winham SJ; Karpyak VM
Drug Alcohol Depend; 2019 Apr; 197():183-190. PubMed ID: 30840924
[TBL] [Abstract][Full Text] [Related]
14. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
[TBL] [Abstract][Full Text] [Related]
15. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
17. A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
Abe K; Shang J; Shi X; Yamashita T; Hishikawa N; Takemoto M; Morihara R; Nakano Y; Ohta Y; Deguchi K; Ikeda M; Ikeda Y; Okamoto K; Shoji M; Takatama M; Kojo M; Kuroda T; Ono K; Kimura N; Matsubara E; Osakada Y; Wakutani Y; Takao Y; Higashi Y; Asada K; Senga T; Lee LJ; Tanaka K
J Alzheimers Dis; 2020; 73(1):217-227. PubMed ID: 31771070
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
19. Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study.
Ding H; Li Y; Ang TFA; Liu Y; Devine S; Au R; Doraiswamy PM; Liu C
J Prev Alzheimers Dis; 2023; 10(3):530-535. PubMed ID: 37357294
[TBL] [Abstract][Full Text] [Related]
20. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
